The designated site of application is typically the upper arm or gluteal muscle for adults, as directed by a healthcare professional
Possible combination research: co-study with probiotics has been proposed, though this is speculative
Individuals under 18 years of age Pregnant or breastfeeding women Individuals with medical conditions (unless approved by a healthcare professional) Anyone advised against metabolic-active compounds Generally well tolerated, but may include: Mild skin irritation Headache Nausea Changes in energy levels Users may experience improved metabolism, increased energy, and gradual improvements in body composition with consistent use
The oral capsule format is of particular interest in this area, since the swallowed peptide is delivered directly into the gastrointestinal tract, where much of this research activity has historically been localised and where the compounds reported stability in gastric conditions is most relevant
A randomized, double-blind, placebo-controlled trial in 191 older adults (75 years) with moderate vitamin B 12 deficiency (serum cobalamin concentrations of 107-210 pmol/L) without anemia provided participants with 1 mg/day of cyanocobalamin for one year (94)
